Paul, thanks for the research and sharing the articles.
Paul, thanks for the research and sharing the articles. They provide context from the other side of the deals and the other side of the world. Since the beginning of COVID I have been begging for a vaccine platform that can mutate (and provide longer immunity) along with these constantly changing viruses. I'm not sure if Ii-key is it, but it seems to fit better than the more popular vaccines in the public consciousness.
Any of us that have been here since bird flu have seen the periodic evolution of SARS type viruses. The viruses come and go and funding and interest wane accordingly. This virus is not going anywhere, except into more and more victims. The symptoms vary so much from person to person that its vaccine has to be more complex than one size fits all. Once again, I think it bears repeating that Dr. EvH has been working on a vaccine platform for 20 years. Time and money (it appears) are on our side this time. Peptides are being ruled in and out, even as we wait for the investing world to discover GNBT/NGIO. COVID is not only something we die with, but given the proper platform, it may be the something we can live with.
I am not a medical researcher, nor do I have a scientific background. I am merely a long time GNBT shareholder. These past 14, nearly 15, years have taught me a lot, but my scenario above may be scientifically inaccurate in some points. For that I apologize, but I think you guys know what I mean.
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...
Continue Reading
Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....
Continue Reading
What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...
Continue Reading
Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...
Continue Reading
Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...
Continue Reading
Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...
Continue Reading
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...
Continue Reading
Top 5 Most Recently Viewed Articles
Teleflex's Strategic Separation Initiative In a significant move to enhance shareholder value, Teleflex Incorporated (NYSE: TFX) plans to separate its business into two independent publicly traded entities. This decision follows a comprehensive evaluation of its business portfolio, and the aim is to streamline operations while focusing on core markets. Creating NewCo and...
Continue Reading
Understanding Boston Scientific's Market Performance Boston Scientific (NYSE: BSX) has been a standout performer in the stock market over the past decade, boasting a remarkable annualized return. Investors who have placed their faith in this innovative medical technology company would be pleased with the results, having realized an annualized growth of 22.01%, which...
Continue Reading
Key Investigation Details on Paysafe Limited Recent developments have brought Paysafe Limited into the spotlight as a law firm initiates an investigation regarding potential securities fraud on behalf of investors. This scrutiny centers on whether the company and its senior management may have breached federal securities laws or engaged in questionable business practices....
Continue Reading
Setting the Stage for Expansion When you hear that Grace Huang and Edward Freeman are hopping onto Latham & Watkins' Hong Kong ship, it's a bit like watching heavyweights enter the ring. Both these pros are bringing a truckload of experience into one of Asia's most competitive markets. This isn't just a small change; it’s a pretty big deal for the firm's capital markets...
Continue Reading
Novele Achieves Certification Milestone Novele, Inc. has made strides in the energy storage sector by securing important certifications for its innovative EnergyBoard product. These certifications, including Large-Scale Fire Burn VOC, ETL, and CB, highlight the product's compliance with key standards for entry into both North American and European markets. A Memorable...
Continue Reading